Insider Transactions Reported by 24 Insiders of IO Biotech, Inc.

Symbol
IOBT on Nasdaq
Location
Copenhagen, Denmark

Insiders trading volume in the past year

IO Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Invest A/s Lundbeckfond Director, 10%+ Owner $14,438,960 09 Aug 2023
Vivo Capital IX, LLC 10%+ Owner $9,510,598 09 Aug 2023
Novo Holdings A/S 10%+ Owner $5,709,989 25 Jul 2024
HBM Healthcare Investments (Cayman) Ltd. 10%+ Owner $2,784,714 09 Nov 2021
Claus A. Andersson Director $1,854,192 09 Nov 2021
Kurma Partners 10%+ Owner $645,248 09 Aug 2023
Vanessa Malier Director $445,544 09 Nov 2021
Amy Sullivan Chief Financial Officer $70,041 02 Apr 2025
Mai-Britt Zocca Chief Executive Officer, Director $61,911 02 Apr 2025
Qasim Iftikhar Ahmad Chief Medical Officer $26,553 02 Apr 2025
Heidi Hunter Director $20,884 +$20,885 05 Jun 2025
Devin W. Smith General Counsel $13,720 02 Apr 2025
Priyanka Belawat Director 04 Nov 2021
Brian Burkavage Chief Accounting Officer 02 Apr 2025
David V Smith Director 05 Jun 2025
Jack Nielsen Director 08 Jun 2023
Kathleen Sereda Glaub Director 05 Jun 2025
Helen Louise Collins Director 05 Jun 2025
Christian E. Elling Director 05 Jun 2025
Muhammad Al-Hajj Chief Scientific Officer 20 Mar 2023
Eva Ehrnrooth Chief Medical Officer 20 Mar 2023
Peter Hirth Director 05 Jun 2025
Emmanuelle Coutanceau Director 04 Nov 2021
Keith A. Vendola Chief Financial Officer 04 Nov 2021

Recent Insider Transactions by Companies or Individuals for IO Biotech, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
David V Smith IOBT Stock Option (Right to Buy) Award 35,144 35,144 05 Jun 2025 Direct
Heidi Hunter IOBT Stock Option (Right to Buy) Award 35,144 35,144 05 Jun 2025 Direct
Peter Hirth IOBT Stock Option (Right to Buy) Award 35,144 35,144 05 Jun 2025 Direct
Kathleen Sereda Glaub IOBT Stock Option (Right to Buy) Award 35,144 35,144 05 Jun 2025 Direct
Christian E. Elling IOBT Stock Option (Right to Buy) Award 35,144 35,144 05 Jun 2025 Direct
Helen Louise Collins IOBT Stock Option (Right to Buy) Award 35,144 35,144 05 Jun 2025 Direct
Heidi Hunter IOBT Common Stock Purchase $20,884 $1.39 15,000 15,000 30 May 2025 Direct
Mai-Britt Zocca IOBT Stock Option (Right to Buy) Award 580,000 580,000 02 Apr 2025 Direct
Amy Sullivan IOBT Stock Option (Right to Buy) Award 215,000 215,000 02 Apr 2025 Direct
Devin W. Smith IOBT Stock Option (Right to Buy) Award 140,000 140,000 02 Apr 2025 Direct
Brian Burkavage IOBT Stock Option (Right to Buy) Award 65,000 65,000 02 Apr 2025 Direct
Qasim Iftikhar Ahmad IOBT Stock Option (Right to Buy) Award 215,000 215,000 02 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.